BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 20, 2006
View Archived Issues
Axcan Pharma reports Q4 highlights
Read More
BioAlliance cleared for phase II/III trial of doxorubicin Transdrug
Read More
Ariad presents novel oral Bcr-Abl kinase inhibitor with broad activity
Read More
Novel HDAC inhibitor shows superiority to vorinostat in vitro
Read More
Promising therapeutics for multiple myeloma presented at the ASH meeting
Read More
Snapshots of newly reported clinical trials in lymphoma
Read More
Progress in clinical developments for Loramyc and acyclovir Lauriad
Read More
Nanobody collaboration achieves first milestone
Read More
Review confirms rEV-131 findings in allergic rhinitis
Read More
Preclinical findings for carrier molecule BP-Cx-1
Read More
Pivotal studies for NM-100060 in onychomycosis begin screening
Read More
Nippon Shinyaku and Roche terminate NS-220 license agreement
Read More
FDA Joint Advisory Committee makes recommendations regarding Ketek
Read More
Advisory Committee recommends alternative phase II study for Hemopure
Read More
Pharmexa and Ichor collaborate on HER-2 DNA AutoVac
Read More
European Commission clearance for Merck KGaA's acquisition of Serono
Read More
Abbott completes acquisition of Kos
Read More
Lilly amends offer for Icos
Read More
Alliance gets French go-ahead for phase II trial of Oxygent
Read More
Enrollment completed in phase IIb study of elocalcitol in BPH
Read More
Ambrisentan NDA filed in pulmonary arterial hypertension
Read More
Astellas resubmits NDA for vernakalant hydrochloride
Read More
Orphan Therapeutics plans rolling NDA for Lucassin
Read More
Novel possible psychopharmacologic drugs identified in recent patents
Read More
Tracleer shows efficacy in mildly symptomatic PAH patients
Read More
New preclinical data on anticonvulsants
Read More
Proellex achieves statistically significant pain reduction in endometriosis
Read More
Sankyo patents novel antiplatelet agents
Read More
Novel analgesic agents imparted in recent Vertex and Gruenenthal patents
Read More